{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:23:23Z","timestamp":1784118203315,"version":"3.55.0"},"reference-count":56,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Multiple disparities have been recognized in the area of location, gender, and funding for leadership in oncology clinical trials. Understanding their intersectionality is crucial to be able to formulate policies and actions, to ensure research is representative of the global oncology community. Here, data from phase III trials presented at the ASCO Annual Meeting of 2022 (ASCO22) were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>The location of institution, gender of lead and senior authors, and funding source for solid tumor phase III trial abstracts presented at the ASCO22 were analyzed. World Bank analytical grouping version 2021-2022 was used to describe regions and countries as high (HIC), upper-middle (UMIC), lower-middle (LoMIC), and low-income (LIC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Across 239 phase III abstracts, lead and senior authors respectively represented HIC institutions in 83% and 85%, UMIC in 13% and 12%, and LoMIC in 4% and 3%. No authors worked in LICs or sub-Saharan Africa. Women accounted for 29% of lead and 23% of senior authors. This distribution persisted across regions, with women as lead authors ranging from 19% (UMIC) to 31% (HIC), and as senior authors from 7% (UMIC) to 25% (HIC). Industry funded 62% of trials, academia 17%, and others 15%; 6% lacked funding. Industry funding was highest in HIC trials (66% for lead and senior authors), followed by UMICs (55% lead, 53% senior) and LoMICs (11% lead, 0% senior). Industry-sponsored trials were proportionally equally represented among female and male senior authors (63% each).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>There is marked intersectionality in leadership of oncology clinical trials presented at the world's largest oncology conference.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/go.24.00238","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T19:59:50Z","timestamp":1727985590000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1690-8198","authenticated-orcid":true,"given":"Laure-Anne","family":"Teuwen","sequence":"first","affiliation":[{"name":"Department of Oncology, Antwerp University Hospital, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-6755","authenticated-orcid":true,"given":"Joanna","family":"Young","sequence":"additional","affiliation":[{"name":"Blue Ridge Cancer Care, Blacksburg, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4588-7410","authenticated-orcid":true,"given":"Saleh","family":"Alessy","sequence":"additional","affiliation":[{"name":"Department of Public Health, Saudi Electronic University, Riyadh, Saudi Arabia"},{"name":"Centre for Cancer, Society &amp; Public Health, Faculty of Life Sciences &amp; Medicine, King's College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-0055","authenticated-orcid":true,"given":"Berna C.","family":"\u00d6zdemir","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Bern University Hospital, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-223X","authenticated-orcid":true,"given":"Diah","family":"Martina","sequence":"additional","affiliation":[{"name":"Division of Psychosomatic and Palliative Medicine, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3339-0378","authenticated-orcid":true,"given":"Sharif","family":"Folorunso","sequence":"additional","affiliation":[{"name":"Clinical and Radiation Oncology, Department of Radiology, Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3116-912X","authenticated-orcid":true,"given":"Maria T.","family":"Bourlon","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Ciencias M\u00e9dicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-7352","authenticated-orcid":true,"given":"Hans","family":"Prenen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Antwerp University Hospital, Edegem, Belgium"},{"name":"Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-6144","authenticated-orcid":true,"given":"Eva","family":"Segelov","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Faculty of Medicine University of Bern and Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/pon.5890"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066637"},{"key":"e_1_3_4_4_2","article-title":"Demarginalizing the intersection of race and sex: A Black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics","volume":"139","author":"Crenshaw KW","year":"1989","unstructured":"Crenshaw KW: Demarginalizing the intersection of race and sex: A Black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics. U Chi Legal F 139, 1989","journal-title":"U Chi Legal F"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","unstructured":"Ramaswami R Paulino E Barrichello A et al: Disparities in breast lung and cervical cancer trials worldwide. JCO Glob Oncol 10.1200\/JGO.17.00226","DOI":"10.1200\/JGO.17.00226"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4259704"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.7478"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.03.009"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","unstructured":"Odedina FT Shamley D Okoye I et al: Landscape of oncology clinical trials in Africa. JCO Glob Oncol 10.1200\/JGO.19.00189","DOI":"10.1200\/JGO.19.00189"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30010050"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00514-z"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb0803929"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2016-000055"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-011338"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-018-0748-6"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01738-x"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2023.701"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00700-7"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa053910"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2196"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","unstructured":"Hornstein P Tuyishime H Mutebi M et al: Authorship equity and gender representation in global oncology publications. JCO Glob Oncol 10.1200\/GO.21.00369","DOI":"10.1200\/GO.21.00369"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14509"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32818"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14787"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6450-5"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2023-000200"},{"key":"e_1_3_4_28_2","unstructured":"ASCO myConnection: All Communities. https:\/\/myconnection.asco.org\/communities\/allcommunities"},{"key":"e_1_3_4_29_2","unstructured":"City Cancer Challenge. https:\/\/citycancerchallenge.org\/international-womens-day-2022\/"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.100781"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000152"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-057474"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003455"},{"key":"e_1_3_4_34_2","unstructured":"ASCO Overview. https:\/\/society.asco.org\/about-asco\/asco-overview"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","unstructured":"Bourlon MT Bhatt AS Lopes G et al: Envisioning academic global oncologists: Proposed competencies for global oncology training from ASCO. JCO Glob Oncol 10.1200\/GO.23.00157","DOI":"10.1200\/GO.23.00157"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","unstructured":"Gralow JR Asirwa FC Bhatt AS et al: Recommendations from the ASCO Academic Global Oncology Task Force. JCO Glob Oncol 10.1200\/GO.20.00497","DOI":"10.1200\/GO.20.00497"},{"key":"e_1_3_4_37_2","unstructured":"2022 ASCO\u00ae Annual Meeting Program Guide. https:\/\/meetings.asco.org\/meetings\/2022-asco-annual-meeting\/288\/program-guide\/scheduled-sessions"},{"key":"e_1_3_4_38_2","unstructured":"World Bank Country and Lending Groups. https:\/\/datahelpdesk.worldbank.org"},{"key":"e_1_3_4_39_2","unstructured":"Ontario Human Rights Commission (OHRC). https:\/\/www.ohrc.on.ca\/en\/policy-preventing-discrimination-because-gender-identity-and-gender-expression\/3-gender-identity-and-gender-expression"},{"key":"e_1_3_4_40_2","unstructured":"Genderize API - GenderAPI.io. https:\/\/genderize.io\/"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","unstructured":"Bourlon MT Jim\u00e9nez Franco B Castro-Alonso FJ et al: Global oncology authorship and readership patterns. JCO Glob Oncol 10.1200\/GO.21.00299","DOI":"10.1200\/GO.21.00299"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","unstructured":"Gyawali B: Me too. JCO Glob Oncol 10.1200\/JGO.2015.000588","DOI":"10.1200\/JGO.2015.000588"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/20502877.2017.1314885"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2021-003296"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32660"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000229"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.0708"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1200\/OP.19.00255"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2014.001464"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000422"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000423"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.41344"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12109-8"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.250"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0031"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2016.11.007"},{"key":"e_1_3_4_57_2","first-page":"1","article-title":"Drug development in low- and middle-income countries: Opportunity or exploitation?","volume":"42","author":"Jalali R","year":"2022","unstructured":"Jalali R, Nogueira-Rodrigues A, Das A, et al: Drug development in low- and middle-income countries: Opportunity or exploitation? Am Soc Clin Oncol Educ Book 42:1-8, 2022","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO.24.00238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T19:59:53Z","timestamp":1727985593000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO.24.00238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1200\/GO.24.00238"],"URL":"https:\/\/doi.org\/10.1200\/go.24.00238","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-05-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400238"}}